Skip to main content
HR 113 117th Congress House

Triple-Negative Breast Cancer Research and Education Act of 2021

Official title: To provide for research and education with respect to triple-negative breast cancer, and for other purposes.

Introduced: February 4, 2021 See on congress.gov
Health CancerGovernment information and archivesHealth information and medical recordsHealth programs administration and funding
More subjectsShow fewer subjects
Health promotion and preventive careMedical educationMedical researchMinority healthResearch administration and fundingWomen's health
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 2, 2021
Referred to the Subcommittee on Health.
Jan 4, 2021
Referred to the House Committee on Energy and Commerce.
Jan 4, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 2, 2021

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Triple-Negative Breast Cancer Research and Education Act of 2021

This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors.

Specifically, the National Institutes of Health must conduct and support research into the disease.

Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1
D
Wilson, Frederica S.
Florida · Feb 4, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 113: Triple-Negative Breast Cancer Research and Education Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-113/
MLA
"H.R. 113: Triple-Negative Breast Cancer Research and Education Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-113/.
Bluebook (legal)
H.R. 113, 117th Cong. (2026), https://openamerica.io/bill/117-HR-113/.
Markdown link
[H.R. 113: Triple-Negative Breast Cancer Research and Education Act of 2021](https://openamerica.io/bill/117-HR-113/)
Report a problem